Supramolecular Drug-Delivery Systems Based on Polymeric Core-Shell Architectures

Angewandte Chemie - International Edition

Volumn 43, Issue 3, 2004, Pages 278-282

  Haag, Rainer ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Block copolymers; Dendrimers; Drug delivery; Micelles; Supramolecular chemistry

Indexed keywords

CELLS; DRUG PRODUCTS; POLYMERS; TISSUE; TUMORS;

NANOCARRIERS;

SUPRAMOLECULAR CHEMISTRY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; MACROGOL; POLYMER;

ANIMAL CELL; BIOCOMPATIBILITY; CELL ACTIVITY; COMPLEX FORMATION; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSPORT; ENDOCYTOSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MICELLE; MOLECULAR INTERACTION; NANOPARTICLE; NONHUMAN; PH; PHYSICAL CHEMISTRY; POLYMERIZATION; POROSITY; PRESSURE; REVIEW; STEREOCHEMISTRY; SUPRAMOLECULAR CHEMISTRY; SURFACE PROPERTY; THERMODYNAMICS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HUMANS; PERMEABILITY; POLYMERS;

EID: 0347761362     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200301694     Document Type: Review

References (60)

1. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 4-25.
2. a) D. D. Lasic, D. Papahadjopoulos, Science 1995, 267, 1275-1276;
3. b) L. Zhang, K. Yu, A. Eisenberg, Science 1996, 272, 1777-1779;
4. c) K. E. Uhrich, Chem. Rev. 1999, 99, 3181-3198;
5. d) C. Allen, A. Eisenberg, J. Mrsic, D. Maysinger, Drug Delivery 2000, 7, 139-145;
6. e) R. Langer, Science 2001, 293, 58-59;
7. f) W. M. Saltzman, Drug Delivery: Engineering Principles for Drug Therapy, Oxford University Press, New York, 2001;
8. g) D. E. Discher, A. Eisenberg, Science 2002, 297, 967-973;
9. h) V. P. Torchilin, Adv. Drug Delivery Rev. 2002, 54, 215-225.
10. K. Kataoka, A. Harada, Y. Nagaski, Adv. Drug Delivery Rev. 2001, 47, 113-131.
11. Y. Kakizawa, K. Kataoka, Adv. Drug Delivery Rev. 2002, 54, 203-222.
12. J. Kreuter, Colloidal Drug Delivery Systems, Marcel Dekker, New York, 1994.
13. For a recent reviews, see M. W. P. L. Baars, E. W. Meijer, Top. Curr Chem. 2000, 210, 131-182.
14. For recent reviews, see a) R. Duncan, Nat. Rev. Drug Discovery 2003, 2, 347-360;
15. b) M. Thanou, R. Duncan, Curr. Opin. Invest. Drugs 2003, 4, 701-709.
16. a) L. Deng, M. Mrksich, G. M. Whitesides, J. Am. Chem. Soc. 1996, 118, 5136-5137;
17. b) I. Szleifer, Curr. Opin. Solid State Mater. Sci. 1997, 2, 337-344.
18. K. Kataoka, G. S. Kwon, M. Yokoyama, T. Okano, Y. Sakurai, J. Controlled Release 1993, 24, 119-132.
19. Pluronics (BASF) are PEO-b-PPO-copolymers, which are frequently used as pharma additives to solubilize drugs.
20. S. M. Moghimi, A. C. Hunter, Pharmacol. Rev. 2001, 53, 283-318.
21. R. Savic, L. Luo, A. Eisenberg, D. Maysinger, Science 2003, 300, 615-618.
22. L. Luo, J. Tam, D. Maysinger, A. Eisenberg, Bioconjugate Chem. 2002, 13, 1259-1265.
23. Y. Takakura, M. Hashida, Crit. Rev. Oncol. Hematol. 1994, 18, 207-231.
24. F. Yuan, M. Deilian, D. Fukumura, M. Leuning, D. A. Berk, V. P. Torchilin, R. K. Jain, Cancer Res. 1995, 55, 3752-3756.
25. Y. Matsumura, H. Maeda, Cancer Res. 1986, 46, 6387-6392.
26. H. Maeda, Y. Matsumura, CRC Crit. Rev. Ther Drug Carrier Syst. 1989, 6, 193-210.
27. H. Ringsdorf, J. Polym. Sci. Polym. Symp. 1975, 51, 135-153.
28. L. Gros, H. Ringsdorf, H. Schupp, Angew. Chem. 1981, 93, 311-322; Angew. Chem. Int. Ed. Engl. 1981, 20, 305-325.
29. L. Gros, H. Ringsdorf, H. Schupp, Angew. Chem. 1981, 93, 311-322; Angew. Chem. Int. Ed. Engl. 1981, 20, 305-325.
30. a) F. Kratz, U. Beyer, M. T. Schütte, Crit. Rev. Ther. Drug Carrier Syst. 1999, 16, 245-288;
31. b) O.L.P. De Jesús, H.R. Ihre, L. Gagne, J. M. J. Fréchet, F. C. J. Szoka, Bioconjugate Chem. 2002, 13, 453-461.
32. F. Kratz, R. Müller-Driver, I. Hofmann, J. Drevs, C. Unger, J. Med. Chem. 2000, 43, 1253-1256.
33. a) R. Duncan, P. Kopeckova-Rejmanova, J. Strohalm, I. C. Hume, J. B. Lloyd, J. Kopecek, Br. J. Cancer 1988, 57, 147-156;
34. b) V. Subr, J. Strohalm, K. Ulbrich, R. Duncan, J. Controlled Release 1992, 18, 123-132.
35. F. Kratz, A. Warnecke, P. C. A. Rodrigues, K. Riebeseel in Polymeric Biomaterials, 2nd ed. (Ed.: S. Dumitriu), Marcel Dekker, New York, 2001, pp. 851-894.
36. Y. Bae, S. Fukushima, A. Harad, K. Kataoka, Angew. Chem. 2003, 115, 4788-4791; Angew. Chem. Int. Ed. 2003, 42, 4640-4643.
37. Y. Bae, S. Fukushima, A. Harad, K. Kataoka, Angew. Chem. 2003, 115, 4788-4791; Angew. Chem. Int. Ed. 2003, 42, 4640-4643.
38. An alternative name for adriamycin (ADR) is doxorubicine (DOXO).
39. L. W. Seymour, Y. Miyamoto, H. Maeda, M. Brereton, J. Strohalm, K. Ulbrich, R. Duncan, Eur. J. Cancer 1995, 31, 766-770.
40. S.-E. Stiriba, H. Frey, R. Haag, Angew. Chem. 2002, 114, 1385-1390; Angew. Chem. Int. Ed. 2002, 41, 1329-1334.
41. S.-E. Stiriba, H. Frey, R. Haag, Angew. Chem. 2002, 114, 1385-1390; Angew. Chem. Int. Ed. 2002, 41, 1329-1334.
42. a) G. R. Newkome, C. N. Moorefield, G. R. Baker, M. J. Saunders, S. H. Grossman, Angew. Chem. 1991, 103, 1207-1209; Angew. Chem. Int. Ed. Engl. 1991, 30, 1178-1180;
43. a) G. R. Newkome, C. N. Moorefield, G. R. Baker, M. J. Saunders, S. H. Grossman, Angew. Chem. 1991, 103, 1207-1209; Angew. Chem. Int. Ed. Engl. 1991, 30, 1178-1180;
44. b) J. F. G. A. Jansen, E. M. M. de Brabander-van den Berg, E. W. Meijer, Science 1994, 266, 1226-1229;
45. c) S. Stevelmans, J. C. M. van Hest, J. F. G. A. Jansen, D. A. F. J. van Boxtel, E. M. M. de Brabander-van den Berg, E. W. Meijer, J. Am. Chem. Soc. 1996, 118, 7398-7399;
46. d) A. P. H. J. Schenning, C. Ellissen-Roman, J.-W. Weener, M. W. P. L. Baars, S. J. van der Gaast, E. W. Meijer, J. Am. Chem. Soc. 1998, 120, 8199-8208;
47. e) V. Chechik, M. Zhao, R. M. Crooks, J. Am. Chem. Soc. 1999, 121, 4910-4911;
48. f) A. Sunder, M. Krämer, R. Hanselmann, R. Mülhaupt, H. Frey, Angew. Chem. 1999, 111, 3758-3761; Angew. Chem. Int. Ed. 1999, 38, 3552-3555;
49. f) A. Sunder, M. Krämer, R. Hanselmann, R. Mülhaupt, H. Frey, Angew. Chem. 1999, 111, 3758-3761; Angew. Chem. Int. Ed. 1999, 38, 3552-3555;
50. g) C. Kojima, K. Kono, K. Maruyama, T. Takagishi, Bioconjugate Chem. 2000, 11, 910-917;
51. h) M. Liu, K. Kono, J. M. J. Fréchet, J. Controlled Release 2000, 65, 121-131;
52. i) A. W. Kleij, R. van de Coevering, R. J. M. Klein Gebbink, A.-M. Noordman, A. L. Spek, G. van Koten, Chem. Eur. J. 2001, 7, 181-192;
53. j) S.-E. Stiriba, H. Kautz, H. Frey, J. Am. Chem. Soc. 2002, 124, 9698-9699;
54. k) C. Kojima, Y. Haba, T. Fukui, K. Kono, T. Takagishi, Macromolecules 2003, 36, 2183-2186.
55. J. F. G. A. Jansen, E. W. Meijer, J. Am. Chem. Soc. 1995, 117, 4417-4418.
56. G. Pistolis, A. Malliaris, D. Tsiourvas, C. M. Paleos, Chem. Eur. J. 1999, 5, 1440-1444.
57. a) Z. Sideratou, D. Tsiourvas, C. M. Paleos, Langmuir 2000, 16, 1766-1769;
58. b) H. Stephan, H. Spies, B. Johannsen, C. Kauffmann, F. Vögtle, Org. Lett. 2000, 2, 2343-2346.
59. M. Krämer, J.-F. Stumbé, H. Türk, S. Krause, A. Komp, L. Delineau, S. Prokhorova, H. Kautz, R. Haag, Angew. Chem. 2002, 114, 4426-4431, Angew. Chem. Int. Ed. 2002, 41, 4252-4256.
60. M. Krämer, J.-F. Stumbé, H. Türk, S. Krause, A. Komp, L. Delineau, S. Prokhorova, H. Kautz, R. Haag, Angew. Chem. 2002, 114, 4426-4431, Angew. Chem. Int. Ed. 2002, 41, 4252-4256.